-: What is Teva's commitment to climate targets
and what do you think the biopharma industry as a whole
should do in order to address this big challenge?
-: I think all of us, whether at work or at home,
need to take climate change seriously
and I think the broader topic of ESG,
which I think you're probably leaning into there.
So Teva's making some significant inroads.
I think the most important thing we're doing
is we've being very transparent
about what we're trying to do.
So we don't say we're behind changing climate
and the environment agenda--
we have actually articulated and clarified
our exact targets of what we're doing.
So greenhouse gas emissions,
how much are we going to reduce them, by when.
So we've listed out exactly what we think
is necessary to help climate change
and what targets we've got,
so we can be held accountable.
We need to make sure that we're part of a global community,
whether that's the environment
or whether that's society,
and we have a responsibility
to make sure people have access to medicines.
The same when it comes to diversity and inclusion.
We're a global company
and we need to make sure we give access
to people from all different types of backgrounds.
I think the industry should take everything, take it seriously,
take the environment seriously,
and industry has an opportunity
to make a significant difference.
As an individual I try and do my best at home,
but that's marginal
and we all have to do it together to have an impact.
But companies, particularly companies
who have manufacturing bases
and research bases can make a difference
when it comes to the environment.
So I think we've got to accept our responsibility
and embrace it and execute on it.